Pharmacotherapy of Tobacco Use Disorder
Categories:
Department of Psychiatry ,
Best Practices in Schizophrenia Treatment (BeST) Center ,
Department of Psychiatry | Tags:
abnormal dreams ,
abstinence ,
acetylcholine ,
addiction ,
adherence ,
adverse effects ,
adverse events ,
agitation ,
antidepressant ,
appetite ,
bipolar disorder ,
bupropion ,
cancer ,
cardiac ,
chest pain ,
cigarettes ,
clinical trial ,
combination drug therapy ,
combination therapy ,
combination treatment ,
consequences ,
diabetes ,
dizziness ,
dopamine ,
dopamine and norepinephrine reuptake inhibitor ,
dopaminergic ,
dose ,
drug ,
Dugan ,
e cigarettes ,
e-cigarette ,
effective ,
efficacy ,
electronic cigarettes ,
epinephrine ,
erectile dysfunction ,
fertility ,
gum ,
headache ,
heart ,
heart disease ,
heart palpitations ,
immune system ,
inhaler ,
insomnia ,
is bupropion effective ,
is nicotine replacement effective ,
is the patch effective ,
is varenicline effective ,
lozenge ,
lung ,
lung disease ,
macular degeneration ,
medication ,
medicine ,
memory ,
Mental Health ,
mental illness ,
monotherapy ,
nasal spray ,
nausea ,
neurotransmitter ,
nicotine ,
nicotine dependence ,
nicotine replacement product ,
nicotine replacement therapy ,
nicotinic acetylcholine receptor ,
non-adherence ,
norepinephrine ,
NRT ,
number needed to treat ,
partial agonist ,
patch ,
pharmacotherapy ,
placebo ,
pleasure ,
quit ,
quit smoking ,
quitting ,
receptor ,
relative risk ,
repeated dosing ,
risks ,
sad ,
Sara ,
Sara Dugan ,
schizoaffective disorder ,
schizophrenia ,
seizure threshold ,
side effects ,
smoking ,
smoking cessation ,
substance use ,
substance use disorder ,
susbstance abuse ,
sympathomimetic ,
systematic review ,
therapy ,
tobacco ,
tobacco abuse ,
tobacco use ,
tobacco use and mental illness ,
treatment ,
tremor ,
vape tobacco use disorder ,
vaping ,
varenicline ,
vomiting
VIDEO
In this lecture, Dr. Dugan discusses the history of tobacco use and reviews the medications that may be effective for smoking cessation. By the end of this lecture, you will be able to: 1) identify pharmacologic targets for treatment of tobacco use disorder, 2) list the adverse effects seen with pharmacologic treatment of tobacco use disorder, and 3) compare the efficacy data for agents used for treatment of tobacco use disorder.